During progression to NASH, adipose tissues modulate the downstream PPAR-α through ADIPOQ, enhancing the oxidation of fatty acids and glucose uptake in NAFLD. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.